Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-17
1992-09-29
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514261, 514272, 514274, 514258, 544265, 544276, 544277, 544278, 544310, 544317, 544313, C07D23902, C07D47300, C07D49500, A61K 3152, A61K 31505
Patent
active
051514265
ABSTRACT:
Methods and compositions for preventing or treating human immunodeficiency virus (HIV) infections characterized by 2-substituted-5-substituted-1,3-oxathiolanes.
REFERENCES:
patent: 4000137 (1975-06-01), Dvonch et al.
patent: 4336381 (1980-11-01), Nagata et al.
Balzarini et al., "Potent and Selective Anti-HTLV-III/LAV Activity of 2',3'-Dideoxycytidinene, the 2',3'-Unsaturated Derivative of 2',3'-Dideoxycytidine", Biochemical and Biophysical Research Communications, 140(2), pp. 735-742 (1986).
Baba et al., "Both 2',3'-Dideoxythymidine and its 2',3'-Unsaturated Derivative (2',3'-Dideoxythymidinene) are Potent and Selective Inihibitors of Human Immunodeficiency Virus Replication in vitro", Biochemical and Biophysical Research Communications, 142(1) pp. 128-134 (1987).
Wainberg et al., "Characterization Of AZT-Resistant Isolates Of HIV-1: Susceptibility To Deoxythiacytidine And Other Nucleosides", Sixth International Conference on AIDS, San Francisco, Calif., vol. 3, Abstract S.B.87, p. 117 (1990).
Norbeck et al., "(+)-Dioxolane-T", Tetrahedron Lett., 30, pp. 6263-6266 (1989).
Wainberg et al., "Anti-HIV Activity, Toxicity And Pharmacokinetics Of Totally Novel Nucleoside Analogs," Fifth International Conference on AIDS, Montreal, Canada, Abstract M.C.P. 63, p. 552, (1989).
Mitsuya et al., "Inhibition of the in vitro Infectivity and Cytopathic Effect of Human T-Lymphotrophic Virus Type III/Lymphadenopathy-Associated Virus (HTLV-III/LAV) by 2',3'-Dideoxynucleosides", Proc. Natl. Acad. Sci. USA, 83, pp. 1911-1915 (1986).
Lin et al., "Synthesis and Antiviral Activity of Various 3'-Azido, 3'-Amino, 2',3'-Unsaturated, and 2',3'-Dideoxy Analogues of Pyrimidine Deoxyribonucleosides against Retroviruses", J. Med. Chem., 30, pp. 440-444 (1987).
Huryn et al., "Synthesis of Iso-ddA, Member Of A Novel Class Of Anti-HIV Agents-Dioxolane-T, A New 2',3,-Dideoxynucleoside Prototype With In Vitro Activity Against HIV", Chemtracts-Organic Chemistry 3, pp. 249-251 (1990).
Mitsuya et al., "3'-Azido-3'-Deoxythymidine (BW A509U): An Antiviral Agent that Inhibits the Infectivity and Cytopathic Effect of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus in vitro", Proc. Natl. Acad. Sci. USA, 82, pp. 7096-7100 (1986).
Gosselin et al., "Systematic Synthesis And Biological Evaluation Of .alpha.- and .beta.-D-Lyxofuranosyl Nucleosides Of The Five naturally Occurring Nucleic Acid Bases", J. Med. Chem., 30, pp. 982-991 (1987).
Herdewijn et al., "3'-Substituted 2',3'-Dideoxynucleoside Analogues as Potential Anti-HIV (HTLV-III/LAV) Agents", J. Med. Chem., 30, pp. 1270-1278 (1987).
Carlisle et al., "Cellular Pharmacology Of The Anti-HIV Agent BCH-189 (2'-Deoxy-3'-Thiacytidine) In Human Peripheral Blood Mononuclear Cells (PBMC)", American Association for Cancer Research Proceedings, 31, abstract 2435, (1990).
Belleau et al., "Design And Activity Of A Novel Class OF Nucleoside Analogs Effective Against HIV-1", Fifth International Conference on AIDS, Montreal, Canada, Abstraact T.C.O. 1 (1989).
Belleau Bernard
Nguyen-Ba Nghe
Biochem Pharma Inc.
Haley, Jr. James F.
McDonell Leslie A.
Tsang Cecilia
LandOfFree
2-substituted-5-substituted-1,3-oxathiolanes with antiviral prop does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted-5-substituted-1,3-oxathiolanes with antiviral prop, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted-5-substituted-1,3-oxathiolanes with antiviral prop will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1968712